Little Green Pharma Ltd
Little Green Pharma Ltd
Your view on LGP.AX
Overview
What the company does, where it operates, and who runs it.
About Little Green Pharma Ltd
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Paul Frederick Long
- Headquarters
- PO Box 101, Wembley, WA, AU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Paul Frederick Long
- Headquarters
- PO Box 101, Wembley, WA, AU
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products.
Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
Stock Data
Price chart, volume, and trading data.
What moved it
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Little Green Pharma Ltd. Starting points for Little Green Pharma Ltd: beta 0.70 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Little Green Pharma Ltd. Little Green Pharma Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Little Green Pharma Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJun 2026 | Next quarterSep 2026 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | AUD 0.00 | AUD 0.01 | AUD 0.01 |
| Lowest estimate | AUD 0.00 | AUD 0.00 | AUD 0.01 | AUD 0.01 |
| Highest estimate | AUD 0.00 | AUD 0.00 | AUD 0.01 | AUD 0.01 |
| Number of analysts | 0 | 0 | 1 | 1 |
| A year ago | −AUD 0.02 | −AUD 0.01 | −AUD 0.001 | — |
| Growth vs a year ago | +100.0% | +100.0% | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterJun 2026 | Next quarterSep 2026 | This yearYear to Mar 2027 | Next yearYear to Mar 2028 |
|---|---|---|---|---|
| Average estimate | AUD 23.48M | AUD 23.72M | AUD 104.10M | AUD 117.50M |
| Lowest estimate | AUD 23.48M | AUD 23.72M | AUD 104.10M | AUD 117.50M |
| Highest estimate | AUD 23.48M | AUD 23.72M | AUD 104.10M | AUD 117.50M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | AUD 12.84M | AUD 8.77M | AUD 42.42M | — |
| Growth vs a year ago | +82.9% | +170.6% | +145.4% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Little Green Pharma Ltd. Little Green Pharma Ltd has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AGN.AXArgenica Therapeutics Ltd | Healthcare | Biotechnology | — | ||
| BDX.AXBCAL Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| EMD.AXEmyria Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| EYE.AXNova Eye Medical Limited | Healthcare | Medical - Devices | — | ||
| IDT.AXIDT Australia Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IIQ.AXINOVIQ Ltd | Healthcare | Medical - Diagnostics & Research | — | ||
| MAP.AXMicroba Life Sciences Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| KSPHFKissei Pharmaceutical Co., Ltd. | Healthcare | OTC | $1.1B | ||
| LABFFLaboratorios Farmaceuticos Rovi, S.A. | Healthcare | OTC | $4.6B | ||
| LABS.TOMediPharm Labs Corp. | Healthcare | TSX | $25.6M | ||
| LEEEFLeef Brands Inc. | Healthcare | OTC | $25.6M | ||
| LEEF.CNLeef Brands Inc. | Healthcare | CNQ | $38.1M | ||
| LFCRLifecore Biomedical, Inc. | Healthcare | NASDAQ | $242.6M | ||
| LITHBioELife Corp. | Healthcare | OTC | — | ||
| LMLLFPharmadrug Inc. | Healthcare | OTC | $746,817 | ||
| LNTHLantheus Holdings, Inc. | Healthcare | NASDAQ | $6.7B | ||
| LOVE.TOCannara Biotech Inc. | Healthcare | TSX | $198.1M | ||
| LOVFFCannara Biotech Inc. | Healthcare | OTC | $125.5M | ||
| LOWLFLowell Farms Inc. | Healthcare | OTC | $1,815 | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Little Green Pharma Ltd.